3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
39
Lymphoma
34
Lymphoma, Follicular
24
Lymphoma, Non-Hodgkin
23
Lymphoma, Mantle-Cell
19
Lymphoma, B-Cell
16
Leukemia, Lymphocytic, Chronic, B-Cell
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Multiple Myeloma
15
Burkitt Lymphoma
14
Lymphoma, B-Cell, Marginal Zone
13
Hodgkin Disease
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
8
Lymphoma, Large-Cell, Anaplastic
8
Glioma
8
Neuroectodermal Tumors, Primitive, Peripheral
7
Neuroblastoma
7
Mycosis Fungoides
7
Lymphoma, T-Cell
7
Histiocytosis, Langerhans-Cell
7
Wilms Tumor
6
Waldenstrom Macroglobulinemia
6
Sarcoma
6
Rhabdoid Tumor
6
Medulloblastoma
6
Lymphoma, T-Cell, Cutaneous
6
Hepatoblastoma
6
Ependymoma
6
Rhabdomyosarcoma
5
Osteosarcoma
5
Interventions
siltuximab
2
fludarabine phosphate
2
fludarabine
2
Interleukin 1 Receptor Antagonist Protein
2
Cyclophosphamide
2
AP 1903 reagent
2
obinutuzumab
1
glofitamab
1
axicabtagene ciloleucel
1
Oxaliplatin
1
Neuropsychological Tests
1
Magnetic Resonance Spectroscopy
1
Gemcitabine
1
Gelsolin
1
Contrast Media
1
Bendamustine Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cytokine Release Syndrome
×
Magnetic Resonance Spectroscopy
×
Lymphoid
×
Clear all
NCT05510596
2024-08-09
MR-ICANS
University Hospital, Montpellier
Phase NA
Completed
25 enrolled